TIRUPATIIN logo

TIRUPATIIN (TIRUPATIIN)

Market Open
11 Aug, 22:00
MSE MSE
6. 18
-0.32
-4.9231%
221.8M Market Cap
- P/E Ratio
- Div Yield
170,464 Volume
0 Eps
6.5
Previous Close
Add Transaction
Day Range
6.18 6.66
Year Range
5.53 14.04
Want to track TIRUPATIIN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

TIRUPATIIN (TIRUPATIIN) Statistics

Valuation metrics

Market Cap 221.8M
Enterprise value 244.09M
Trailing P/E (ttm) 6.99
Forward P/E -
PEG ratio 0.08
Price/Sales (ttm) 0.27
Price/Book (mrq) 0.36
Enterprise Value/Revenue 0.3
Enterprise Value/EBITDA 18.33

Overview

Shares outstanding 26.44M
Float 23.3M
Shares short -
% Held by insiders 0.02%
% Held by institutions -
Average volume (10 days) 223.77K
Average volume (90 days) 396.64K

Price summary

52-Week low 5.53
52-Week high 14.04
Beta 0.55
50-Day moving average 8.8
200-Day moving average 8.52

Financials

Fiscal year

Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin 0.04%
Operating margin 0.02%

Operational effectiveness

Return on assets 0.01%
Return on equity 0.02%

Income Statement

Revenue (ttm) 816.3M
Revenue per share (ttm) 33.42
Quarterly revenue growth (yoy) 56.54%
Gross profit (ttm) 51.16M
EBITDA 42.31M
Net income to common (ttm) 31.64M
Diluted EPS (ttm) 1.2
Quarterly earnings growth (yoy) 0.8%

Balance Sheet

Total cash (mrq) 591K
Total cash per share (mrq) 0.03
Total debt (mrq) 46.45M
Total Debt/Equity (mrq) 8.12
Current ratio (mrq) 2.09%
Book value per share (mrq) 23.4

Cash Flow

Cash flow statement -143.59M
Levered free cash flow (LFCF) 9.96M